LIFE Atyr Pharma Inc
aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.
$2.80 0.00 (0.00%)
As of 05/26/2022 16:00:01 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 05/07/2015
Outstanding shares: 28,056,249
Average volume: 87,381
Market cap: $78,557,497
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol:
Valuation (See tab for details)
PE ratio: -4.15
PB ratio: 0.80
PS ratio: 0.00
Return on equity: -39.34%
Net income %: -1,384,272.07%